CIK 0001447028 · Non-accelerated filer<br>Smaller reporting company
Arbutus Biopharma Corp
Sign in to watch- Ticker
- ABUS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- EIN
- 980597776
- Phone
- 604-419-3200
- Business address
- 701 VETERANS CIRCLE, WARMINSTER, PA, 18974
- Former names
- TEKMIRA PHARMACEUTICALS CORP, TEKMIRA PHARMACEUTICALS Corp
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Grant or award General Counsel and CCO acquired 54,300 shares (grant or award)
- 4 Grant or award Interim President & CEO acquired 177,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 90,100 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 49,300 shares (grant or award)
- 4 Planned sale Chief Financial Officer sold 22,183 shares at $3.28 ($72,827)
- 4 Planned sale Chief Medical Officer sold 19,348 shares at $3.28 ($63,519)
- 4 Planned sale Interim President & CEO sold 23,790 shares at $3.28 ($78,103)
- 4 Planned sale General Counsel and CCO sold 11,333 shares at $3.28 ($37,206)
- 4 Open-market sale Director sold 8,846 shares at $3.69 ($32,637)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 2 of 14 · 274 filings